Geneos Wealth Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.39M Buy
77,196
+38,337
+99% +$2.68M 0.13% 192
2025
Q1
$2.86M Buy
38,859
+22,801
+142% +$1.68M 0.04% 407
2024
Q4
$1.05M Sell
16,058
-336
-2% -$22K 0.04% 413
2024
Q3
$1.28M Buy
16,394
+1,666
+11% +$130K 0.05% 356
2024
Q2
$1.15M Sell
14,728
-194
-1% -$15.1K 0.05% 339
2024
Q1
$1.01M Buy
14,922
+4,573
+44% +$310K 0.05% 345
2023
Q4
$697K Sell
10,349
-911
-8% -$61.4K 0.03% 398
2023
Q3
$763K Sell
11,260
-743
-6% -$50.3K 0.04% 368
2023
Q2
$859K Buy
12,003
+525
+5% +$37.6K 0.05% 342
2023
Q1
$797K Sell
11,478
-1,424
-11% -$98.8K 0.05% 344
2022
Q4
$875K Sell
12,902
-302
-2% -$20.5K 0.05% 299
2022
Q3
$724K Buy
13,204
+232
+2% +$12.7K 0.05% 314
2022
Q2
$855K Sell
12,972
-440
-3% -$29K 0.04% 362
2022
Q1
$889K Sell
13,412
-835
-6% -$55.3K 0.04% 387
2021
Q4
$829K Buy
14,247
+1,754
+14% +$102K 0.03% 451
2021
Q3
$745K Buy
12,493
+47
+0.4% +$2.8K 0.03% 469
2021
Q2
$756K Buy
12,446
+7,243
+139% +$440K 0.03% 449
2021
Q1
$276K Sell
5,203
-1,714
-25% -$90.9K 0.01% 838
2020
Q4
$304K Buy
6,917
+3,877
+128% +$170K 0.01% 670
2020
Q3
$168K Buy
3,040
+625
+26% +$34.5K 0.01% 739
2020
Q2
$127K Sell
2,415
-332
-12% -$17.5K 0.01% 813
2020
Q1
$116K Sell
2,747
-415
-13% -$17.5K 0.01% 791
2019
Q4
$159K Buy
3,162
+165
+6% +$8.3K 0.01% 785
2019
Q3
$135K Hold
2,997
0.01% 786
2019
Q2
$123K Buy
2,997
+250
+9% +$10.3K 0.01% 831
2019
Q1
$111K Buy
2,747
+332
+14% +$13.4K 0.01% 826
2018
Q4
$91K Sell
2,415
-184
-7% -$6.93K 0.01% 866
2018
Q3
$102K Sell
2,599
-336
-11% -$13.2K 0.01% 872
2018
Q2
$103K Hold
2,935
0.01% 777
2018
Q1
$102K Sell
2,935
-993
-25% -$34.5K 0.01% 743
2017
Q4
$136K Buy
3,928
+697
+22% +$24.1K 0.01% 650
2017
Q3
$109K Buy
3,231
+300
+10% +$10.1K 0.01% 673
2017
Q2
$99K Sell
2,931
-1,329
-31% -$44.9K 0.01% 679
2017
Q1
$132K Sell
4,260
-90,883
-96% -$2.82M 0.01% 586
2016
Q4
$2.6M Buy
95,143
+45,861
+93% +$1.25M 0.34% 82
2016
Q3
$1.63M Buy
49,282
+30,700
+165% +$1.01M 0.22% 111
2016
Q2
$565K Buy
18,582
+7,951
+75% +$242K 0.08% 224
2016
Q1
$300K Buy
+10,631
New +$300K 0.05% 336